VEGF, IGF-1 and FGF-2 Serum Levels in Children and Adolescents with Autism Spectrum Disorder with and without Bipolar

Gokce Guldiken1, Ali Karayagmurlu2, Canan Kucukgergin3

  • 1Health Ministry of Turkish Republic Reyhanlı State Hospital, Hatay, Turkey. drgokceguldiken@gmail.com.

Insights

Serum levels of vascular endothelial growth factor (VEGF) and fibroblast growth factor 2 (FGF-2) were higher in children with autism spectrum disorder (ASD) and bipolar disorder (BD). These growth factors may serve as potential biomarkers for BD in young individuals with ASD.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pediatrics

Background:

  • Autism spectrum disorder (ASD) and bipolar disorder (BD) are complex neurodevelopmental conditions.
  • Co-occurrence of ASD and BD presents unique diagnostic and management challenges in children and adolescents.
  • Identifying reliable biomarkers is crucial for early diagnosis and effective treatment.

Purpose of the Study:

  • To investigate serum levels of vascular endothelial growth factor (VEGF), insulin-like growth factor 1 (IGF-1), and fibroblast growth factor 2 (FGF-2).
  • To explore the relationship between these growth factors and clinical characteristics in children and adolescents with ASD, with and without comorbid BD.
  • To assess the potential of these factors as biomarkers for BD in the ASD population.

Main Methods:

  • A study group of 40 subjects with ASD and BD was compared to a control group of 40 subjects with ASD.
  • Serum samples were analyzed for VEGF, IGF-1, and FGF-2 using enzyme-linked immunosorbent assay (ELISA) kits.
  • Clinical characteristics, including ASD severity, self-harming behavior, sleep disturbance, and BD episode history, were assessed.

Main Results:

  • The ASD + BD group exhibited significantly higher ASD severity, self-harming behavior, and sleep disturbances compared to the ASD-only group.
  • Serum levels of VEGF and FGF-2 were significantly elevated in the ASD + BD group versus the ASD group.
  • No significant difference in IGF-1 levels was observed; however, VEGF correlated negatively with age at BD diagnosis, and IGF-1 correlated positively with the number of bipolar episodes.

Conclusions:

  • Elevated serum VEGF and FGF-2 may indicate potential biomarkers for bipolar disorder in young individuals with autism spectrum disorder.
  • These findings suggest that VEGF and FGF-2 could aid clinicians in diagnosing and monitoring BD in this specialized pediatric population.
  • Further research is warranted to confirm the utility of VEGF and FGF-2 as clinical biomarkers for managing comorbid BD in children and adolescents with ASD.
Abstract

Related Concept Videos

Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
139
Bipolar Disorder01:30

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
102
Modeling in Therapy01:26

Modeling in Therapy

Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
119